CA2813472A1 - Encres amorphes cristallines a solidification rapide - Google Patents
Encres amorphes cristallines a solidification rapide Download PDFInfo
- Publication number
- CA2813472A1 CA2813472A1 CA 2813472 CA2813472A CA2813472A1 CA 2813472 A1 CA2813472 A1 CA 2813472A1 CA 2813472 CA2813472 CA 2813472 CA 2813472 A CA2813472 A CA 2813472A CA 2813472 A1 CA2813472 A1 CA 2813472A1
- Authority
- CA
- Canada
- Prior art keywords
- group
- phase change
- ink
- change ink
- crystalline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Landscapes
- Inks, Pencil-Leads, Or Crayons (AREA)
- Ink Jet (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2813472 CA2813472A1 (fr) | 2012-04-26 | 2013-04-19 | Encres amorphes cristallines a solidification rapide |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/547,271 | 2012-07-12 | ||
CA 2813472 CA2813472A1 (fr) | 2012-04-26 | 2013-04-19 | Encres amorphes cristallines a solidification rapide |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2813472A1 true CA2813472A1 (fr) | 2013-10-26 |
Family
ID=49475990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2813472 Abandoned CA2813472A1 (fr) | 2012-04-26 | 2013-04-19 | Encres amorphes cristallines a solidification rapide |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2813472A1 (fr) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9732080B2 (en) | 2006-11-03 | 2017-08-15 | Vertex Pharmaceuticals Incorporated | Azaindole derivatives as CFTR modulators |
US10071979B2 (en) | 2010-04-22 | 2018-09-11 | Vertex Pharmaceuticals Incorporated | Process of producing cycloalkylcarboxamido-indole compounds |
US10081621B2 (en) | 2010-03-25 | 2018-09-25 | Vertex Pharmaceuticals Incorporated | Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide |
US10206877B2 (en) | 2014-04-15 | 2019-02-19 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases |
-
2013
- 2013-04-19 CA CA 2813472 patent/CA2813472A1/fr not_active Abandoned
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9732080B2 (en) | 2006-11-03 | 2017-08-15 | Vertex Pharmaceuticals Incorporated | Azaindole derivatives as CFTR modulators |
US10081621B2 (en) | 2010-03-25 | 2018-09-25 | Vertex Pharmaceuticals Incorporated | Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide |
US10071979B2 (en) | 2010-04-22 | 2018-09-11 | Vertex Pharmaceuticals Incorporated | Process of producing cycloalkylcarboxamido-indole compounds |
US10206877B2 (en) | 2014-04-15 | 2019-02-19 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2775192C (fr) | Compositions d'encre solides comprenant des esters amorphes de l'acide citrique | |
CA2813480C (fr) | Compositions d'encre a changement de phase comportant des composes sulfones cristallins et derives de celles-ci | |
US9938422B2 (en) | Phase change inks comprising crystalline amides | |
US9051486B2 (en) | Phase change ink components and methods of making the same | |
CA2774656A1 (fr) | Encres a changement de phase et methodes de fabrication connexes | |
US20130284054A1 (en) | Rapid solidifying crystalline-amorphous inks | |
US9528015B2 (en) | Phase change ink compositions comprising crystalline diurethanes and derivatives thereof | |
CA2813358C (fr) | Compositions d'encre amorphe cristalline a cristallisation rapide et leurs methodes de fabrication | |
CA2813484C (fr) | Compositions d'encre a changement de phase comportant des ethers aromatiques | |
US9228101B2 (en) | Rapidly crystallizing phase change inks and methods for forming the same | |
CA2813360C (fr) | Encres a changement de phase comprenant des pigments organiques | |
CA2813472A1 (fr) | Encres amorphes cristallines a solidification rapide | |
US8647423B2 (en) | Phase change inks comprising fatty acids | |
US8882897B2 (en) | Phase change inks comprising aromatic diester crystalline compounds | |
US9580615B2 (en) | Phase change inks comprising inorganic nucleating agents | |
CA2838482A1 (fr) | Materiaux amorphes a utiliser dans les encres de changement de phase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |
Effective date: 20160420 |